Indomethacin
( DrugBank: Indomethacin / KEGG DRUG: Indomethacin, Indomethacin sodium )
3 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 225 | Congenital nephrogenic diabetes insipidus | 1 |
| 271 | Ankylosing spondylitis | 3 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 298 | Hereditary pancreatitis | 1 |
225. Congenital nephrogenic diabetes insipidus
Clinical trials : 19 / Drugs : 56 - (DrugBank : 21) / Drug target genes : 33 - Drug target pathways : 67
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
271. Ankylosing spondylitis
Clinical trials : 631 / Drugs : 405 - (DrugBank : 73) / Drug target genes : 38 - Drug target pathways : 144
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
298. Hereditary pancreatitis
Clinical trials : 126 / Drugs : 210 - (DrugBank : 59) / Drug target genes : 65 - Drug target pathways : 161
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|